New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in ...

Bausch Health and Lannett have settled a decadelong lawsuit regarding claims the drugmakers colluded to inflate generic drug prices, according to court documents filed in the U.S. District Court for ...

The pharma major said it faces the largest drug-patent expiry headwind in its history this year.

Drug companies Lannett and Bausch agreed to pay $18 million over alleged price-fixing as part of far-reaching lawsuits ...

South Carolina Attorney General Alan Wilson announced Wednesday that he joined several other states and territories on ...

Novartis AG — with U.S. headquarters in North Jersey — drove up the price of 31 generic drugs through price fixing and bid ...

Tennessee Attorney General Jonathan Skrmetti announced Tuesday that states nationwide have secured settlements totaling ...

Michigan AG Nessel secured $17.85 million in settlements with Lannett and Bausch over drug price-fixing claims.

The settlement totals to $17.85 million for patients who bought specific generic drugs from 2009 to 2019 and administrative ...

The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...

Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March after the drug’s patent expiry, becoming one of the first firms to capture ...

Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...